加利福尼亚州安大略省2024年7月24日/美通社/——垂直农业技术和基础设施领域的领导者Nature’s Miracle Holdings Inc.(纳斯达克股票代码:NMHI)(“Nature’s Miracle”或“公司”)今天宣布，该公司已从加利福尼亚州一家顶级室内种植商那里获得了价值240万美元的infinity LED生长灯采购订单。订单的付款将于2024年10月1日开始，交货日期为2024年11月底。

自然奇迹很高兴加入加州最大的种植者之一作为其主要客户。这一订单是大自然奇迹团队努力建立关系的证明，形成了一个行业网络，推动了公司的收入增长目标。该订单进一步巩固了艾菲尼迪在室内生长轻工业的领先地位。240万美元的销售订单将使公司2024年第四季度的收入增加相同数量。

管理评论

自然奇迹董事长兼首席执行官李小加表示:“今天，我们宣布了自然奇迹历史上最大的单笔订单，展示了自然奇迹产品的深度和质量，并专注于为室内种植行业的客户群提供一流的服务。240万美元的销售订单将在2024年第四季度记录，这反映了公司2024年第一季度记录的季度收入总额为220万美元的收入增长数倍。我们感谢客户对我们的infinity产品和相关服务的兴趣和信心。”

一个关于自然奇迹控股有限公司

Nature's Miracle (www.Nature-Miracle.com)是一家不断发展的农业技术公司，为北美的受控环境农业(“CEA”)行业(包括垂直农业)种植者提供设备和服务。大自然的奇迹提供硬件来设计、建造和操作各种室内种植环境，包括温室和室内种植空间。Nature’s Miracle通过其两家全资子公司(Visiontech Group, Inc.和Hydroman, Inc.)，为北美数百家室内种植者提供生长灯和其他水培产品。自然奇迹还开发了一个强大的管道，在美国和加拿大建立商业规模的温室，以满足对新鲜和当地蔬菜产品日益增长的需求。Nature’s Miracle已经在北美建立了第一个生产基地，在加拿大马尼托巴省建立了生长灯装配厂，并预计将在北美建立更多的生产/组装设施。

前瞻性陈述

Except for historical information contained herein, this press release contains certain "forward-looking statements" within the meaning of the federal U.S. securities laws with respect to the proposed business combination between Lakeshore and Nature's Miracle, the benefits of the transaction, the amount of cash the transaction will provide Nature's Miracle, the anticipated timing of the transaction, the services and markets of Nature's Miracle, our expectations regarding future growth, results of operations, performance, future capital and other expenditures, competitive advantages, business prospects and opportunities, future plans and intentions, results, level of activities, performance, goals or achievements or other future events. These forward-looking statements generally are identified by words such as "anticipate," "believe," "expect," "may," "could," "will," "potential," "intend," "estimate," "should," "plan," "predict," or the negative or other variations of such statements, reflect our management's current beliefs and assumptions and are based on the information currently available to our management. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual results or developments to differ materially from those expressed or implied by such forward-looking statements, including but not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of Lakeshore's securities; (ii) the risk that the transaction may not be completed by Lakeshore's business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by Lakeshore; (iii) the failure to satisfy the conditions to the consummation of the transaction, including the approval of the business combination agreement by the stockholders of Lakeshore, the satisfaction of the minimum cash amount following any redemptions by Lakeshore's public stockholders and the receipt of certain governmental and regulatory approvals; (iv) the lack of a third-party valuation in determining whether or not to pursue the proposed transaction; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement; (vi) the effect of the announcement or pendency of the transaction on Nature's Miracle's business relationships, operating results and business generally; (vii) risks that the proposed transaction disrupts current plans and operations of Nature's Miracle; (viii) the outcome of any legal proceedings that may be instituted against Nature's Miracle or Lakeshore related to the business combination agreement or the proposed transaction; (ix) the ability to maintain the listing of Lakeshore's securities on a national securities exchange; (x) changes in the competitive industries in which Nature's Miracle operates, variations in operating performance across competitors, changes in laws and regulations affecting Nature's Miracle's business and changes in the combined capital structure; (xi) the ability to implement business plans, forecasts and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities; (xii) the risk of downturns in the market and Nature's Miracle's industry including, but not limited to, as a result of the COVID-19 pandemic; (xiii) costs related to the transaction and the failure to realize anticipated benefits of the transaction or to realize estimated pro forma results and underlying assumptions, including with respect to estimated stockholder redemptions; (xiv) risks and uncertainties related to Nature's Miracle's business, including, but not limited to risks relating to the uncertainty of the projected financial information with respect to Nature's Miracle; risks related to Nature's Miracle's limited operating history, the roll-out of Nature's Miracle's business and the timing of expected business milestones; Nature's Miracle's ability to implement its business plan and scale its business; Nature's Miracle's ability to develop products and technologies that are more effective or commercially attractive than competitors' products;; risks relating to Nature's Miracle's being unable to renew the leases of their facilities and warehouses; Nature's Miracle's ability to grow the size of its organization and management in response of the increase of sales and marketing infrastructure; risks relating to potential tariffs or a global trade war that could increase the cost of Nature's Miracle's products; risks relating to product liability lawsuits that could be brought against Nature's Miracle;; Nature's Miracle's ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth; Nature's Miracle's ability to expand internationally; acceptance by the marketplace of the products and services that Nature's Miracle markets; and government regulations and Nature's Miracle's ability to obtain applicable regulatory approvals and comply with government regulations. The foregoing list of factors is not exclusive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section of proxy statement, when available, and other documents filed by Lakeshore from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and neither Nature's Miracle nor Lakeshore assume any obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. Neither Lakeshore nor Nature's Miracle gives any assurance that either Lakeshore or Nature's Miracle, or the combined company, will achieve its expectations.

联系George Yutuc首席财务官George.Yutuc@nature-miracle.com

MZ北美Shannon Devine / Rory Rumore Main: 203-741-8811 NMHI@mzgroup.us

分享本文

点击分享到